OBJECTIVE: Our purpose was to evaluate the frequency and patterns of the shedding of herpes simplex virus and cytomegalovirus in the female genital tract throughout the menstrual cycle. STUDY DESIGN: Seventeen women, all seropositive for herpes simplex virus types 1 and 2, cytomegalovirus, and human immunodeficiency virus type 1, underwent daily evaluation of cervical viral shedding for the duration of 1 menstrual cycle (21-31 visits per woman). Serum estradiol and progesterone levels were monitored 3 times weekly. RESULTS: Overall, herpes simplex virus deoxyribonucleic acid was detected in 43 (10%) of 450 cervical swabs, and cytomegalovirus deoxyribonucleic acid was detected in 232 (52%) of 450 cervical swabs. For individual women there was considerable variability in the percentage of days on which virus was detected, ranging from 0% to 33% for herpes simplex virus and from 20% to 97% for cytomegalovirus. Shedding of herpes simplex virus did not vary significantly with menstrual cycle; however, shedding of cytomegalovirus was significantly more frequent in the luteal phase (odds ratio, 1.9; 95% confidence interval, 1.1-3.4). A CD4(+) lymphocyte count <200/microL was associated with increased frequency of the detection of herpes simplex virus (odds ratio, 5.7; 95% confidence interval, 1.1-29.4). CONCLUSIONS: Asymptomatic cervical shedding of both herpes simplex virus and cytomegalovirus occurs very frequently in women infected with human immunodeficiency virus type 1. The risk of transmitting these viruses to sexual partners and neonates may be higher than previously recognized.
OBJECTIVE: Our purpose was to evaluate the frequency and patterns of the shedding of herpes simplex virus and cytomegalovirus in the female genital tract throughout the menstrual cycle. STUDY DESIGN: Seventeen women, all seropositive for herpes simplex virus types 1 and 2, cytomegalovirus, and human immunodeficiency virus type 1, underwent daily evaluation of cervical viral shedding for the duration of 1 menstrual cycle (21-31 visits per woman). Serum estradiol and progesterone levels were monitored 3 times weekly. RESULTS: Overall, herpes simplex virus deoxyribonucleic acid was detected in 43 (10%) of 450 cervical swabs, and cytomegalovirus deoxyribonucleic acid was detected in 232 (52%) of 450 cervical swabs. For individual women there was considerable variability in the percentage of days on which virus was detected, ranging from 0% to 33% for herpes simplex virus and from 20% to 97% for cytomegalovirus. Shedding of herpes simplex virus did not vary significantly with menstrual cycle; however, shedding of cytomegalovirus was significantly more frequent in the luteal phase (odds ratio, 1.9; 95% confidence interval, 1.1-3.4). A CD4(+) lymphocyte count <200/microL was associated with increased frequency of the detection of herpes simplex virus (odds ratio, 5.7; 95% confidence interval, 1.1-29.4). CONCLUSIONS: Asymptomatic cervical shedding of both herpes simplex virus and cytomegalovirus occurs very frequently in women infected with human immunodeficiency virus type 1. The risk of transmitting these viruses to sexual partners and neonates may be higher than previously recognized.
Entities:
Keywords:
Africa; Africa South Of The Sahara; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Herpes Genitalis--women; Hiv Infections--women; Infections; Kenya; Menstrual Cycle; Menstruation; Physical Examinations And Diagnoses; Reproduction; Reproductive Tract Infections--women; Research Report; Screening; Sexually Transmitted Diseases--women; Viral Diseases; Women
Authors: George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim Journal: Pediatr Infect Dis J Date: 2013-11 Impact factor: 2.129
Authors: Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen Journal: J Gen Virol Date: 2015-12 Impact factor: 3.891
Authors: Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke Journal: MMWR Recomm Rep Date: 2009-09-04
Authors: Thomas L Cherpes; James L Busch; Brian S Sheridan; Stephen A K Harvey; Robert L Hendricks Journal: J Immunol Date: 2008-07-15 Impact factor: 5.422
Authors: Clare Tanton; Helen A Weiss; Jerome LeGoff; John Changalucha; Tim C Clayton; David A Ross; Laurent Belec; Richard J Hayes; Deborah Watson-Jones Journal: Sex Transm Infect Date: 2011-06-08 Impact factor: 3.519
Authors: A E Aiello; B Jayabalasingham; A M Simanek; A Diez-Roux; L Feinstein; H C S Meier; B L Needham; J B Dowd Journal: Epidemiol Infect Date: 2017-09-07 Impact factor: 4.434
Authors: E R Begnel; A L Drake; J Kinuthia; D Matemo; M-L Huang; K H Ásbjörnsdóttir; V Chohan; K Beima-Sofie; G John-Stewart; D Lehman; J Slyker Journal: Clin Exp Immunol Date: 2020-12-20 Impact factor: 5.732
Authors: Jennifer B Dowd; Jos A Bosch; Andrew Steptoe; Elizabeth H Blackburn; Jue Lin; Erin Rees-Clayton; Allison E Aiello Journal: Exp Gerontol Date: 2013-02-09 Impact factor: 4.032